Back to Holocene Advisors, LP Holocene Advisors, LP

REGNREGN
14 quarters

Position history for Holocene Advisors, LPHolocene Advisors, LP's holdings in REGENERON PHARMACEUTICALS

Holocene Advisors, LP previously held 0 shares of REGN (REGENERON PHARMACEUTICALS), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$76.7M

Total Shares Change

-122,952

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$766.66
0
2025-Q4
Increased
460,723
+203.6%
$355.6M0.7%$773.94
71
2025-Q3
New
151,733
-
$85.3M0.2%$560.05
49
2024-Q2
Exited
0
-100.0%
$00.0%$1,045.23
0
2024-Q1
Decreased
81,857
-77.3%
$78.8M0.3%$957.18
0
2023-Q4
Increased
360,480
+102.8%
$316.6M1.2%$873.45
79
2023-Q3
Increased
177,753
+10.5%
$146.3M0.6%$818.42
47
2023-Q2
Increased
160,862
+25.4%
$115.6M0.5%$704.51
44
2023-Q1
Increased
128,249
+77.7%
$105.4M0.5%$807.02
64
2022-Q4
New
72,176
-
$52.1M0.3%$717.51
49
2021-Q1
Exited
0
-100.0%
$00.0%$468.07
0
2020-Q4
New
1,498
-
$724,0000.0%$475.66
34
2020-Q3
Exited
0
-100.0%
$00.0%$570.45
0
2020-Q2
New
122,952
-
$76.7M0.7%$607.50
58

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used